首页> 外文期刊>Pediatric Research >Metabolism of Branched-Chain Amino Acids in Fibroblasts from Patients with Maple Syrup Urine Disease and Other Abnormalities of Branched-Chain Ketoacid Dehydrogenase Activity
【24h】

Metabolism of Branched-Chain Amino Acids in Fibroblasts from Patients with Maple Syrup Urine Disease and Other Abnormalities of Branched-Chain Ketoacid Dehydrogenase Activity

机译:枫糖浆尿病患者的成纤维细胞中支链氨基酸的代谢及支链酮酸脱氢酶活性的其他异常

获取原文
           

摘要

The metabolism of branched-chain amino acids was studied in cultured fibroblasts from patients with branched-chain ketoacid dehydrogenase deficiency using 1-14C- and UL-14C-leucine and valine. The formation of 14CO2 from 1-14C-valine or 1-14C-leucine was 1-3% of normal. In fibroblasts of patients with associated lactic acidemia the values were 4-29% of control. Analysis of organic acid products revealed that in both patients and controls the amount of labeled α-ketoisovalerate recovered after incubation with 1-14C-valine was one-third of the amount of α-ketoisocaproate recovered after incubation with 1-l4C-leucine. Very little α-hydroxyisocaproate was produced, while the amount of α-hydroxyisovalerate was about 10% of the α-ketoisovalerate. Unexpectedly β-hydroxyisobutyrate ws found to be the major metabolic product of UL-14C-valine in normal fibroblasts. Large accumulations of β-hydroxyisovalerate were found in normal fibroblasts using UL-I4C-leucine. There were little or no conversions to these compounds in fibroblasts of patients with branched-chain ketoacid dehydrogenase deficiency. There were substantial conversions in the patients in whom dehydrogenase deficiency was associated with lactic acidemia.
机译:使用1-14C-和UL-14C-亮氨酸和缬氨酸,在患有支链酮酸脱氢酶缺乏症患者的培养的成纤维细胞中研究了支链氨基酸的代谢。 1-14C-缬氨酸或1-14C-亮氨酸形成14CO2的比例为正常值的1-3%。在伴有乳酸血症的患者的成纤维细胞中,该值是对照的4-29%。有机酸产物的分析显示,在这两个患者和对照中,与1-14C-缬氨酸孵育后回收的标记α-酮异戊酸酯的量是与1-1-4C-亮氨酸孵育后回收的α-酮异己酸酯的量的三分之一。产生很少的α-羟基异己酸,而α-羟基异戊酸的量为α-酮异戊酸的约10%。出乎意料的是,β-羟基异丁酸酯是正常成纤维细胞中UL-14C-缬氨酸的主要代谢产物。使用UL-I4C-亮氨酸在正常成纤维细胞中发现了大量的β-羟基异戊酸积累。支链酮酸脱氢酶缺乏症患者的成纤维细胞几乎没有转化为这些化合物。脱氢酶缺乏症与乳酸血症相关的患者发生了实质性转变。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号